Form 4: SpringWorks Therapeutics Executive James Cassidy Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Chief Medical Officer James Cassidy of SpringWorks Therapeutics reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On August 30, 2024, James Cassidy, Chief Medical Officer of SpringWorks Therapeutics, Inc., had 1,969 shares of common stock withheld by the issuer to satisfy tax obligations.
- This transaction occurred at a price of $41.71 per share.
- Following the transaction, Cassidy directly owns 73,856 shares of SpringWorks Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to tax obligations, and does not contain information that would significantly impact investor sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 08/30/2024 | Date of the stock transaction (tax withholding). |
| 09/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.